期刊文献+

培哚普利治疗高血压病76例 被引量:4

Peridopril in treating 76 cases of essential hypertension
暂未订购
导出
摘要 目的 :通过与卡托普利对比 ,评价培哚普利治疗高血压的疗效 ,以及对血清总胆固醇 (TC)、三酰甘油 (TG)、血糖 (Glu)、肌酐 (Cr)等的影响。方法 :回顾性分析 12 6例 1~ 2级高血压病患者的临床资料 ,培哚普利组 76例 (培哚普利 2~ 4mg ,qd) ;卡托普利组 5 0例 (国产卡托普利 2 5~ 5 0mg ,tid)。疗程均为 4wk ,治疗前后有水银柱血压计的偶测BP和 2 4h动态BP记录 ,以及清晨空腹测量血清TC ,TG ,Glu ,Cr等指标。结果 :2组治疗后偶测BP ,2 4h平均BP和BP负荷均明显降低 ,培哚普利组的总有效率明显高于卡托普利组 (96 1%vs80 % ,P <0 0 5 ) ,峰谷比值培哚普利也明显优于卡托普利 (SBP :6 8 6mmHgvs 4 8 7mmHg ,DBP :70 2mmHgvs 5 1 4mmHg ,P <0 0 5 ) ,2组刺激性咳嗽的发生率类似 (15 8%vs 18% ,P >0 0 5 )。培哚普利组治疗后TG ,Glu比治疗前明显降低。结论 :培哚普利是一种安全有效的控制高血压的药物 ,疗效明显优于国产卡托普利 ; AIM: To evaluate the efficacy of peridopril in the treatment of hypertention and effect on serum total cholesterol (TC), triglycerides (TG), glucose (Glu) and creatinine, comparing with captopril. METHODS: One hundred and twenty six cases of 1-2 grade essential hypertension were analyzed retrospectively. There were 76 cases in peridopril group treated with peridopril (2-4 mg, qd). There were 50 cases in captopril group treated with captopril made in China (25-50 mg, tid). RESULTS: After 4 wk treatment, odd BP, 24 h mean BP and BP load were decreased markedly in 2 groups. The total effective rate of peridopril group was higher than that of captopril group (96 1% vs 80%, P <0 05). Trough∶peak ratio of peridopril was greater than captopril (SBP, 68 6 mmHg vs 48 7 mmHg, P <0 05; DBP, 70 2 mmHg vs 51 4 mmHg, P <0 05). Occurrence rate of cough was comparable in 2 groups (15 8% vs 18%, P >0 05). TG and Glu level was lowered after treated with peridopril. CONCLUSION: Peridopril is a safe and effective drug to control hypertension, its efficacy is better than captopril. Peridopril can improve the metablism of ester and glucose in essential hypertension patients.
出处 《中国临床药学杂志》 CAS 2002年第4期201-204,共4页 Chinese Journal of Clinical Pharmacy
关键词 治疗 高血压病 培哚普利 疗效 hypertention peridopril efficacy
  • 相关文献

参考文献2

共引文献1448

同被引文献19

  • 1张建军,高国梁,董伟峰,严肖峰.尼莫地平在高血压脑出血术后的降压疗效[J].中国新药与临床杂志,2005,24(5):379-382. 被引量:10
  • 2黄宗勤.实用心血管诊疗手册[M].北京:人民卫生出版社,1993:559-573.
  • 3RUBO J, ALBRECHT K, LASCH P, et al. High dose intravenous immune globulin therapy for hyperbilirubinemia caused by RH hemolytic disease[J]. J Pediatr, 1992, 121(1): 93-97.
  • 4CELERMAJER D S, SORENSEN K E, GOOCH V M, et al.Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[J]. Lancet, 1992, 340(8828):1111-1115.
  • 5GUO W,TURLAPATY P,SHEN Y, et al. Clinical experience with perindopril in patients nonresponsive to previous antihypertensive therapy:a large US community trial[J]. Am J Ther, 2004,11(3):199-205.
  • 6TADDEI S, VIRDIS A, MATTEI P, et al. Vasodilation to acetylcholine in primary and secondary forms of human hypertension [J]. Hypertension, 1993,21(6 Pt 2):929-933.
  • 7CARDILLO C, PANZA J A. Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertention[J]. Vasc Med, 1998,3(2):138-144.
  • 8DANANBERG J, SIDER R S, GREKIN R J. Sustained hypertension induced by orally administered nitro-L-arginine[J]. Hypertension, 1993,21(3) :359-363.
  • 9SHEPHERD J T, KATUSIC Z S. Endothelium derived vasoactive factor: Endothelium dependent relaxation [J].Hypertension, 1991,18(Suppl 5) :76-85.
  • 10FINGERLE J, MULLER R M, KUHN H, et al. Mechanism of inhibition of neointimal formation by the angiotension-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries [J]. Arteroscler Thromb Vase Biol. 1995.15(11):1945-1950.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部